Outcomes of Using LNMES on Tracheostomized Children

Children's Hospital Los Angeles

Status: Withdrawn

Conditions: Trachea

Treatments: Device: VitalStim; Other: Traditional Therapy

Study type: Interventional

Funder types: Other

Identifiers

NCT03227627

CHLA-17-00081

Details and patient eligibility

About

Tracheostomy tubes are known to have a negative impact on swallowing. Dysphagia treatment includes using laryngoneuromuscular electrical muscular stimulation (LNMES). Evidence exist on the efficacy of LNMES in the treatment of dysphagia in adults, and scarce in pediatrics. There is no literature available for the efficacy of LNMES in the treatment of dysphagia on patients with tracheostomy tubes. The purpose of this study to determine the outcomes on dysphagia on children with tracheostomy tubes when treated using LNMES. Furthermore, the investigators aim to determine the relationship between parental stress and a child's modified diet.

Sex: All

Ages: 30 days to 5 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

PATIENT COHORT

• Children between 0-4 years 11 months
• Currently have tracheostomy tubes
• MBSS must indicate penetrations of more than 50% of swallows or aspiration of thin, ½ nectar-thick, nectar-thick or honey-thick liquids.
• The child must be on a modified diet of honey-thick liquids, nectar-thick liquids, ½ nectar-thick liquids, or no liquids by mouth.
• Able to tolerate a voice valve PARENT COHORT
• At least one primary caregiver of a qualifying child (see Child cohort).
• Parent/caregiver must be at least 18 years of age or older, provide primary care, and have medical decision making rights for the child.

Exclusion criteria

PATIENT COHORT

• Children who are not on modified diets or using a g-tube as an alternate means of nutrition
• Children with suspected or diagnosed heart problems
• Children with suspected or diagnosed epilepsy
• Children with a tendency to hemorrhage following acute trauma or fracture
• Children who have undergone recent surgical procedures when muscle contraction may disrupt the healing process
• Children for whom the LNMES would be: 1) over carotid sinus, 2) over neoplasm, 3) over active infection and 4) over areas of skin which lack normal sensation
• Children with difficulty tolerating tactile stimulation and tolerate the whole duration of the LNMES sessions.
• Children with difficulty tolerating tactile sensory stimulation such as tape and electrodes on the anterior aspect of the neck.

PARENT COHORT

• The caregiver that does not provide the primary care of the child and does not have medical decision making right
• Parents under 18

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)

---

0 participants in 2 patient groups

VitalStim

Experimental group

Description:

One group of children (Group A) will receive 24 sessions of NMES for combined with traditional therapy including oral motor exercises and laryngeal exercises will be performed to the participants. The equipment to be used for NMES is VitalStim®. VitalStim is a product of Empi®. VitalStim® therapy involves the placement of electrodes to the muscles of the throat that is attached to a device that provides electrical stimulation. The intensity will be increased according to the subject's tolerance and when a "therapeutic" level is reached. Signs of reaching therapeutic level include changes in audible quality of swallows, triggers of swallows, and changes in quality of voice. This therapy is to be performed by a VitalStim® certified practitioner.

Treatment:

Device: VitalStim

Traditional therapy

Active Comparator group

Description:

The other group (Group B) will be receiving 24 sessions of traditional dysphagia therapy.

Treatment:

Other: Traditional Therapy